← All stocks

PTC THERAPEUTICS, INC.

PTCT Scheduled selling only
CIK 0001070081 #1239 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$5.17M
$4.96M on a plan · $204.13K straight out of an exercise
Sold at will
$0.00
0 of 14 sales
Net
−$5.17M
$0.00 against sales at will

By person

18 insiders · 14 transactions
26.9×

Matthew B. Klein holds 26.9 times base salary in stock. $25.85M of shares against $958.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew B. Klein last reported holding, valued at $67.34, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
SCHMERTZLER MICHAEL
Director
$4.96M (12) scheduled
−$4.96M
2,816,454
$189.66M
−1.1%
Boulding Mark Elliott
EXEC. VP AND CLO
$204.13K (2) scheduled
−$204.13K
105,272
$7.09M
+13.9%
Klein Matthew B.
CHIEF EXECUTIVE OFFICER
383,868
$25.85M
+68.8%
Gravier Pierre
CHIEF FINANCIAL OFFICER
83,986
$5.66M
+52.8%
Golden Lee Scott
EVP & CHIEF MEDICAL OFFICER
79,115
$5.33M
+29.3%
Pauwels Eric
CHIEF BUSINESS OFFICER
73,411
$4.94M
+10.3%
Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER
70,199
$4.73M
+30.5%
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER
63,036
$4.24M
−32.7%
Sollie-Zetlmayer Hege Elisabeth
Director
52,526
$3.54M
+12.9%
ZELDIS JEROME B
Director
22,500
$1.52M
+55.2%
STEELE GLENN JR MD PHD
Director
22,500
$1.52M
+55.2%
Smith Mary L.
Director
21,813
$1.47M
+57.9%
Jacobson Allan Steven
Director
21,451
$1.44M
+31.2%
Young Alethia
Director
21,067
$1.42M
+61.2%
SOUTHWELL DAVID P
Director
20,850
$1.40M
+62.3%
Reeve Emma
Director
10,666
$718.25K
−4.8%
Okey Stephanie
Director
8,000
$538.72K
−34.4%
Chutter Jessica Caroline
Director
7,333
$493.80K

No percentages here. This company's share count has moved by a factor of 10.1 over the window, from 8,294,933 to 83,460,802 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
SCHMERTZLER MICHAEL
10 Sep 2026
Director
Sold on a plan indirect
10,000
$67.34
$673.40K
SCHMERTZLER MICHAEL
9 Sep 2026
Director
Sold on a plan indirect
572
$68.67
$39.28K
SCHMERTZLER MICHAEL
9 Sep 2026
Director
Sold on a plan indirect
9,428
$67.79
$639.12K
SCHMERTZLER MICHAEL
27 Aug 2026
Director
Sold on a plan indirect
610
$72.22
$44.05K
SCHMERTZLER MICHAEL
27 Aug 2026
Director
Sold on a plan indirect
11,890
$71.55
$850.73K
SCHMERTZLER MICHAEL
26 Aug 2026
Director
Sold on a plan indirect
5,626
$73.18
$411.71K
SCHMERTZLER MICHAEL
26 Aug 2026
Director
Sold on a plan indirect
6,874
$72.74
$500.01K
SCHMERTZLER MICHAEL
20 Aug 2026
Director
Sold on a plan indirect
691
$72.92
$50.39K
SCHMERTZLER MICHAEL
20 Aug 2026
Director
Sold on a plan indirect
2,390
$71.88
$171.79K
SCHMERTZLER MICHAEL
20 Aug 2026
Director
Sold on a plan indirect
9,419
$70.78
$666.68K
SCHMERTZLER MICHAEL
19 Aug 2026
Director
Sold on a plan indirect
7,165
$73.67
$527.85K
SCHMERTZLER MICHAEL
19 Aug 2026
Director
Sold on a plan indirect
5,335
$72.86
$388.71K
Boulding Mark Elliott
17 Aug 2026
EXEC. VP AND CLO
Sold after exercise
969
$72.90
$70.64K
Boulding Mark Elliott
17 Aug 2026
EXEC. VP AND CLO
Sold after exercise
1,844
$72.39
$133.49K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,813
History held since 26 Sep 2016